Kelly Rouster-Stevens

• Improving Hepatitis B Screening Prior to Rituximab

  Open Access•D Sofia Villacis-Nunez, Evan Orenstein et al.•ARTICLE•Children•2023

  Incluir item

  Rituximab, used in the treatment of some rheumatic and kidney diseases, can lead to hepatitis B virus (HBV) reactivation; HBV screening is recommended for those starting this medication. We aimed to improve by 50% the proportion of patients undergoing HBV screening by implementing multimodal interventions to support clinicians in this evidence-based practice. We conducted a quality improvement project from November 2020 to June 2022 at a tertiary…

• Clinical Determinants of Childhood Onset Systemic Lupus Erythematosus among Early and Peri-Adolescent Age Groups

  Open Access•Meghan Corrigan Nelson, Shanmuganathan Chandrakasan et al.•ARTICLE•Children•2022

  Incluir item

  Introduction: Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease that is associated with significant morbidity and mortality. SLE disproportionately affects women and minorities. Childhood-onset SLE (cSLE) in particular tends to be more aggressive than adult-onset SLE. Despite substantial improvements in the treatment of cSLE, there is significant variability in treatment responses and long-term outcomes. Furthermore, there is…

• Clinical Determinants of Childhood Onset Systemic Lupus Erythematosus among Early and Peri-Adolescent Age Groups

  Open Access•Meghan Corrigan Nelson, Shanmuganathan Chandrakasan et al.•ARTICLE•Children•2022

  Incluir item

  Introduction: Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease that is associated with significant morbidity and mortality. SLE disproportionately affects women and minorities. Childhood-onset SLE (cSLE) in particular tends to be more aggressive than adult-onset SLE. Despite substantial improvements in the treatment of cSLE, there is significant variability in treatment responses and long-term outcomes. Furthermore, there is…

• Improving Hepatitis B Screening Prior to Rituximab

  Open Access•D Sofia Villacis-Nunez, Evan Orenstein et al.•ARTICLE•Children•2023

  Incluir item

  Rituximab, used in the treatment of some rheumatic and kidney diseases, can lead to hepatitis B virus (HBV) reactivation; HBV screening is recommended for those starting this medication. We aimed to improve by 50% the proportion of patients undergoing HBV screening by implementing multimodal interventions to support clinicians in this evidence-based practice. We conducted a quality improvement project from November 2020 to June 2022 at a tertiary…

Immunology (2 obras) · Internal Medicine (2 obras) · Medicine (2 obras) · Pediatrics (2 obras) · Age of onset (1 obra) · Cohort (1 obra) · Disease (1 obra) · Epidemiology (1 obra) · Family medicine (1 obra) · HBsAg (1 obra)